РусскийEnglish (UK)
     
 

Публикации с 2016 года

Кол-во строк: 
# Заголовок
11 Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c.

Gomez Rosso L, Lhomme M, Meroño T, Dellepiane A, Sorroche P, Hedjazi L, Zakiev E, Sukhorukov V, Orekhov A, Gasparri J, Chapman MJ, Brites F, Kontush A.
Biochim Biophys Acta. 2016 Nov 2. pii: S1388-1981(16)30301-8. doi: 10.1016/j.bbalip.2016.10.014. [Epub ahead of print]

12 Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.

Chistiakov DA, Orekhov AN, Bobryshev YV.
Int J Cardiol. 2016 Nov 9;227:66-82. doi: 10.1016/j.ijcard.2016.11.204. [Epub ahead of print]

13 Peroxisome proliferator-activated receptor (PPAR) gamma agonists as therapeutic agents for cardiovascular disorders: Focus on atherosclerosis.

Ivanova EA, Myasoedova VA, Melnichenko AA, Orekhov AN.
Curr Pharm Des. 2016 Nov 18. [Epub ahead of print]

14 CD68/macrosialin: not just a histochemical marker.

Chistiakov DA, Killingsworth MC, Myasoedova VA, Orekhov AN, Bobryshev YV.

Lab Invest. 2016 Nov 21. doi: 10.1038/labinvest.2016.116. [Epub ahead of print]

15 Carbohydrate composition of circulating multiple-modified low-density lipoprotein.

Zakiev ER1, Sobenin IA2, Sukhorukov VN1, Myasoedova VA1, Ivanova EA3, Orekhov AN4.
Vasc Health Risk Manag. 2016 Oct 14;12:379-385. eCollection 2016.

16 Epigenetically active drugs inhibiting DNA methylation and histone deacetylation.

Chistiakov DA, Myasoedova VA, Orekhov AN, Bobryshev YV.
Curr Pharm Des. 2016 Oct 21. [Epub ahead of print]

17 Mutations of mitochondrial DNA in chronic non-inflammatory diseases: target candidates for treatment.

Galitsyna EV, Sazonova MA, Shkurat TP, Demakova NA, Melnichenko AA, Sinyov VV, Ryzhkova AI, Mitrofanov KY, Zhelankin AV, Sobenin IA, Orekhov AN.

Curr Pharm Des. 2016 Oct 18. [Epub ahead of print]

18 Sialidases: Therapeutic And Antiatherogenic Potential.

Sukhorukov VN, Karagodin VP, Zakiev ER, Orekhov AN.
Curr Pharm Des. 2016 Oct 19. [Epub ahead of print]

19 Paraoxonase and atherosclerosis-related cardiovascular diseases

Chistiakov DA, Melnichenko AA, Orekhov AN, Bobryshev YV.
Biochimie. 2016 Oct 19. pii: S0300-9084(16)30284-X. doi: 10.1016/j.biochi.2016.10.010. [Epub ahead of print]

20 PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.

Nikolic D, Castellino G, Banach M, Toth PP, Ivanova E, Orekhov AN, Montalto G, Rizzo M.
Curr Pharm Des. 2016 Oct 6. [Epub ahead of print]